Study identification

EU PAS number

EUPAS41463

Study ID

48937

Official title and acronym

Moderna mRNA-1273 Observational Pregnancy Outcome Study (COVID-19)

DARWIN EU® study

No

Study countries

Canada
United States

Study status

Ongoing
Research institutions and networks

Institutions

IQVIA
United Kingdom
First published:
22/04/2024
Institution Non-Pharmaceutical company ENCePP partner

Contact details

Eleonora Staines Urias

Primary lead investigator

Study timelines

Date when funding contract was signed

Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Moderna
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

EU RMP category 3 (required)